0000914062-13-000365.txt : 20131203
0000914062-13-000365.hdr.sgml : 20131203
20131203170455
ACCESSION NUMBER: 0000914062-13-000365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131202
FILED AS OF DATE: 20131203
DATE AS OF CHANGE: 20131203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAULDIN JOHN F
CENTRAL INDEX KEY: 0001522480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 131255032
MAIL ADDRESS:
STREET 1: 3204 BEVERLY DRIVE
CITY: DALLAS
STATE: TX
ZIP: 75205
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-12-02
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001522480
MAULDIN JOHN F
C/O GALECTIN THERAPEUTICS INC.
4960 PEACHTREE INDUSTRIAL BLVD, STE 240
NORCROSS
GA
30071
1
0
0
0
Common Stock
2013-12-02
4
P
0
609
8.1967
A
17456
D
Common Stock
4947
I
By Trust
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.
Reflects weighted average price. Range of prices were between $8.19 and $8.20. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
/s/ Jack W. Callicutt, Attorney-in-Fact
2013-12-03